Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hepatocellular carcinoma. Part 2. Treatment].

V P Conte1

  • 1Departamento de Gastroenterologia da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP.

Arquivos De Gastroenterologia
|January 6, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Chronic hepatitis by C virus. Part 2. Treatment].

Arquivos de gastroenterologia·2001
Same author

[Chronic viral hepatitis C. Part 1. General considerations].

Arquivos de gastroenterologia·2001
Same author

[Hepatocellular carcinoma. Part 1. General considerations and diagnosis].

Arquivos de gastroenterologia·2000
Same author

[Oddi's sphincter dysfunction].

Revista do Hospital das Clinicas·1991
Same author

Normal neuronal features of the human gallbladder and structural changes in cholelithiasis patients.

Revista do Hospital das Clinicas·1989
Same author

[Non-surgical treatment of biliary lithiasis].

Revista do Hospital das Clinicas·1989

Hepatocellular carcinoma treatment is evolving beyond surgery. Emerging therapies include targeted agents, liver transplantation, and interventions like chemoembolization, offering new hope for patients with inoperable liver cancer.

Area of Science:

  • Hepatology and Oncology
  • Cancer Therapeutics
  • Surgical Oncology

Context:

  • Hepatocellular carcinoma (HCC) management presents challenges due to advanced disease at diagnosis.
  • Surgical resection is often not feasible for many HCC patients.
  • Existing treatments have limitations for extensive or multifocal tumors with cirrhosis.

Purpose:

  • To review recent advancements in hepatocellular carcinoma treatment.
  • To evaluate the role of surgery and alternative therapies for HCC.
  • To explore novel therapeutic strategies including drug combinations and interventional procedures.

Summary:

  • Surgical intervention for HCC is limited by tumor burden and liver function.
  • Alternative treatments include transcatheter arterial chemoembolization, percutaneous injections, and chemotherapy.

Related Experiment Videos

  • Emerging therapies like retinoic acid metabolism blocking agents, octreotide, and interstitial laser coagulation show promise.
  • Angiogenesis regulation is a potential new liver function impacting HCC growth.
  • Early detection and treatments like Recombinant-Interferon-alpha for chronic hepatitis C can prevent HCC.
  • Liver transplantation offers improved long-term survival for select HCC patients.

    • Impact:

    • Novel therapeutic approaches may improve survival rates for inoperable HCC.
    • Understanding angiogenesis regulation could lead to new cancer prevention and treatment strategies.
    • Early HCC recognition and effective management of chronic hepatitis C are crucial for better patient outcomes.
    • Liver transplantation is an increasingly viable option for advanced HCC, offering better long-term survival.